Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Pharmaceutical Chemicals
Canadian chemistry CROs NuChem and OmegaChem to merge
by Michael McCoy
August 19, 2021
| A version of this story appeared in
Volume 99, Issue 30
Credit: NuChem
NuChem's chemistry research lab in Saint-Laurent, Quebec
NuChem Sciences has acquired OmegaChem, creating what it says is Canada’s largest contract research organization (CRO) providing drug discovery chemistry. Three Canadian investment companies are putting up a combined $30 million to support the deal. NuChem says it will have 200 scientists and support staffers. Formed in 2011, NuChem employs many chemists who worked at drug firms such as AstraZeneca that closed labs in Quebec.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter